| __timestamp | Novavax, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 45967000 |
| Thursday, January 1, 2015 | 162644000 | 114737000 |
| Friday, January 1, 2016 | 237939000 | 183204000 |
| Sunday, January 1, 2017 | 168435000 | 231644000 |
| Monday, January 1, 2018 | 173797000 | 293998000 |
| Tuesday, January 1, 2019 | 113842000 | 357355000 |
| Wednesday, January 1, 2020 | 747027000 | 412084000 |
| Friday, January 1, 2021 | 2534508000 | 497153000 |
| Saturday, January 1, 2022 | 1235278000 | 705789000 |
| Sunday, January 1, 2023 | 737502000 | 648449000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ultragenyx Pharmaceutical Inc. and Novavax, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Novavax's R&D expenses surged by over 900%, peaking in 2021 with a remarkable 2.5 billion USD. This spike coincides with the global demand for vaccines, highlighting Novavax's pivotal role in addressing public health challenges. Meanwhile, Ultragenyx's R&D spending grew steadily, reaching its highest in 2022, with a 15% increase from the previous year. This consistent growth underscores Ultragenyx's strategic focus on developing treatments for rare diseases.
As these companies continue to innovate, their R&D investments will likely shape the future of healthcare.
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
R&D Spending Showdown: Zoetis Inc. vs Novavax, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Ultragenyx Pharmaceutical Inc.
Biogen Inc. or Novavax, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
R&D Insights: How Opthea Limited and Novavax, Inc. Allocate Funds
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Novavax, Inc.
Analyzing R&D Budgets: Iovance Biotherapeutics, Inc. vs Novavax, Inc.